RN
Ramesh Navaladi
About Ramesh Navaladi
Data last updated:
Ramesh Navaladi is a Director at Disruptive Health Solutions Private Limited (since 2019) and Director at Fenway Pharmaceuticals Private Limited (since 2021). The companies operate in Pharma. The 2 current companies with reported revenue have a combined latest revenue of ₹22.81 Cr; the largest is Disruptive Health Solutions Private Limited at ₹15.23 Cr (FY 2022).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 15 Jul 2019 | 2014 | ₹15.23 Cr (FY 2022) | Active | |
| Director | 09 Jun 2021 | 2021 | ₹7.58 Cr (FY 2022) | Active |
Board colleagues of Ramesh Navaladi
| Name | DIN | Company | Designation |
|---|---|---|---|
| Akshay Navaladi | 07004429 | Disruptive Health Solutions Private Limited , Fenway Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Ramesh Navaladi
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ramesh Navaladi
Ramesh Navaladi currently holds 2 directorships: Disruptive Health Solutions Private Limited (Director, since 15 Jul 2019, revenue ₹15.23 Cr (FY 2022)); Fenway Pharmaceuticals Private Limited (Director, since 09 Jun 2021, revenue ₹7.58 Cr (FY 2022)).
Ramesh Navaladi was first appointed on 15 Jul 2019 as Director at Disruptive Health Solutions Private Limited. The most recent appointment on record is 09 Jun 2021 at Fenway Pharmaceuticals Private Limited.
The 2 current companies of Ramesh Navaladi that report revenue have a combined latest revenue of ₹22.81 Cr: Disruptive Health Solutions Private Limited ₹15.23 Cr (FY 2022); Fenway Pharmaceuticals Private Limited ₹7.58 Cr (FY 2022).
The current boards of Ramesh Navaladi's companies include Akshay Navaladi (Disruptive Health Solutions Private Limited).